Now showing items 1-1 of 1

    • Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas. 

      Pierce, DB; Johnson, GE; Monroe, E; Loggers, ET; Jones, RL; Pollack, SM; Padia, SA (2018-01)
      OBJECTIVE: The outcome for patients with unresectable hepatic sarcoma is poor with a median survival period of 12-16 months. The purpose of this study was to evaluate liver-directed transcatheter therapies for the treatment ...